CDC, FDA recommend US pause use of Johnson & Johnson's COVID-19 vaccine over blood clot concerns
The FDA and the Centers for Disease Control and Prevention are reviewing reports of rare and severe blood clots from six people who received the vaccine.
Source: wxii12.com